primary membranous nephropathy

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Membranous Nephropathy Trial in Australia (Obinutuzumab, Oral prednisolone and cyclophosphamide)

Not yet recruiting
  • Primary Membranous Nephropathy
  • Garran, Australian Capital Territory, Australia
  • +12 more
Nov 1, 2023

Primary Membranous Nephropathy Trial (MIL62, Cyclosporine)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
May 16, 2023

Primary Membranous Nephropathy Trial (EVER001)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Mar 23, 2023

Primary Membranous Nephropathy Trial (Zanubrutinib, Tacrolimus)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Jan 23, 2023

Primary Membranous Nephropathy Trial (SNP-ACTH (1-39) Gel, Rituximab)

Not yet recruiting
  • Primary Membranous Nephropathy
  • (no location specified)
Jan 13, 2023

Primary Membranous Nephropathy Trial in Worldwide (Obinutuzumab, Tacrolimus, Methylprednisolone)

Recruiting
  • Primary Membranous Nephropathy
  • Mesa, Arizona
  • +75 more
Jan 10, 2023

Primary Membranous Nephropathy Trial in Beijing (B007)

Not yet recruiting
  • Primary Membranous Nephropathy
  • Beijing, China
    Peking university first hospital
Dec 20, 2022

Primary Membranous Nephropathy Trial in China (SHR1459 Low Dose, SHR1459 High Dose, Placebo)

Recruiting
  • Primary Membranous Nephropathy
  • SHR1459 Low Dose
  • +2 more
  • Hefei, Anhui, China
  • +19 more
Jul 8, 2022

Primary Membranous Nephropathy Trial in Beijing (MIL62, Cyclosporine)

Recruiting
  • Primary Membranous Nephropathy
  • Beijing, Beijing, China
    Peking University First Hospital
May 26, 2022